These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 32075785)

  • 1. Using a clinical process map to identify prescribing cascades in your patient.
    Piggott KL; Mehta N; Wong CL; Rochon PA
    BMJ; 2020 Feb; 368():m261. PubMed ID: 32075785
    [No Abstract]   [Full Text] [Related]  

  • 2. Prescribing cascades in older adults.
    Sternberg SA; Guy-Alfandary S; Rochon PA
    CMAJ; 2021 Feb; 193(6):E215. PubMed ID: 33558408
    [No Abstract]   [Full Text] [Related]  

  • 3. Polypharmacy in chronic diseases-Reduction of Inappropriate Medication and Adverse drug events in older populations by electronic Decision Support (PRIMA-eDS): study protocol for a randomized controlled trial.
    Sönnichsen A; Trampisch US; Rieckert A; Piccoliori G; Vögele A; Flamm M; Johansson T; Esmail A; Reeves D; Löffler C; Höck J; Klaassen-Mielke R; Trampisch HJ; Kunnamo I
    Trials; 2016 Jan; 17():57. PubMed ID: 26822311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deprescribing: a new goal focused on the patient.
    Machado-Alba JE; Gaviria-Mendoza A; Machado-Duque ME; Chica L
    Expert Opin Drug Saf; 2017 Feb; 16(2):111-112. PubMed ID: 27984921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prescribing cascades: we see only what we look for, we look for only what we know.
    O'Mahony D; Rochon PA
    Age Ageing; 2022 Jul; 51(7):. PubMed ID: 35776668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Understanding and reducing the risk of adverse drug reactions in pediatric patients].
    Gotta V; van den Anker J; Pfister M
    Ther Umsch; 2015 Dec; 72(11-12):679-86. PubMed ID: 26654811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reducing polypharmacy: evidence from a simple quality improvement initiative.
    Little MO; Morley A
    J Am Med Dir Assoc; 2013 Mar; 14(3):152-6. PubMed ID: 23273343
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical medication reviews in elderly patients with polypharmacy: a cross-sectional study on drug-related problems in the Netherlands.
    Chau SH; Jansen AP; van de Ven PM; Hoogland P; Elders PJ; Hugtenburg JG
    Int J Clin Pharm; 2016 Feb; 38(1):46-53. PubMed ID: 26597955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Inappropriate prescribing in the elderly].
    Pepersack T
    Rev Med Brux; 2013 Sep; 34(4):295-300. PubMed ID: 24195243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polypharmacy Reduction Strategies: Tips on Incorporating American Geriatrics Society Beers and Screening Tool of Older People's Prescriptions Criteria.
    Levy HB
    Clin Geriatr Med; 2017 May; 33(2):177-187. PubMed ID: 28364990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Licence to Prescribe.
    Kramers C; Janssen BJ; Knol W; Hessel MHM; Mulder WM; Dumont G; Maassen van den Brink A; Tichelaar J
    Br J Clin Pharmacol; 2017 Aug; 83(8):1860-1861. PubMed ID: 28256012
    [No Abstract]   [Full Text] [Related]  

  • 12. [Polymedication among elderly patients Preventing drug related problems and inappropriate medication].
    Patris S
    J Pharm Belg; 2016 Sep; (3):4-9. PubMed ID: 30281238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. International Group for Reducing Inappropriate Medication Use & Polypharmacy (IGRIMUP): Position Statement and 10 Recommendations for Action.
    Mangin D; Bahat G; Golomb BA; Mallery LH; Moorhouse P; Onder G; Petrovic M; Garfinkel D
    Drugs Aging; 2018 Jul; 35(7):575-587. PubMed ID: 30006810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Algorithm of medication review in frail older people: Focus on minimizing the use of high-risk medications.
    Poudel A; Ballokova A; Hubbard RE; Gray LC; Mitchell CA; Nissen LM; Scott IA
    Geriatr Gerontol Int; 2016 Sep; 16(9):1002-13. PubMed ID: 26338275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adverse drug events due to potentially inappropriate medications.
    Sakuma M; Morimoto T
    Arch Intern Med; 2011 Nov; 171(21):1959; author reply 1960. PubMed ID: 22123812
    [No Abstract]   [Full Text] [Related]  

  • 16. Combating Polypharmacy Through Deprescribing Potentially Inappropriate Medications.
    Chou J; Tong M; Brandt NJ
    J Gerontol Nurs; 2019 Jan; 45(1):9-15. PubMed ID: 30653232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deprescribing to Reduce Medication Use: Will This Help Your Patient?
    Howland RH
    J Psychosoc Nurs Ment Health Serv; 2016 Nov; 54(11):21-24. PubMed ID: 27805712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug dosing in elderly patients with chronic kidney disease.
    Lassiter J; Bennett WM; Olyaei AJ
    Clin Geriatr Med; 2013 Aug; 29(3):657-705. PubMed ID: 23849014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frailty, polypharmacy and deprescribing.
    Drug Ther Bull; 2016 Jun; 54(6):69-72. PubMed ID: 27284125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reducing inappropriate polypharmacy: the process of deprescribing.
    Scott IA; Hilmer SN; Reeve E; Potter K; Le Couteur D; Rigby D; Gnjidic D; Del Mar CB; Roughead EE; Page A; Jansen J; Martin JH
    JAMA Intern Med; 2015 May; 175(5):827-34. PubMed ID: 25798731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.